Literature DB >> 9048508

Diagnosis and treatment of irritable bowel syndrome.

C B Dalton1, D A Drossman.   

Abstract

Irritable bowel syndrome is a common disorder characterized by symptoms of abdominal pain with diarrhea and/or constipation. It is associated with significant disability and health care costs. A practical approach to diagnosis utilizes the symptom-based Rome criteria. Management of patients has been helped by recent findings relating to the pathophysiology of the disorder. Dysregulation of intestinal motor functions, sensory functions and central nervous system functions is currently believed to be the basis for irritable bowel symptoms. Symptoms are a result of both abnormal intestinal motility and enhanced visceral sensitivity. Psychosocial factors can affect the illness experience and the clinical outcome. An effective physician-patient relationship is required for a successful outcome. Individualized treatment involves an integrated pharmacologic and behavioral approach determined by the predominant symptom type, the severity of the symptoms and the degree of disability.

Entities:  

Mesh:

Year:  1997        PMID: 9048508

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  4 in total

Review 1.  Irritable bowel syndrome.

Authors:  S M Turner; J E Stewart; J J Alexopulos; J S Hill
Journal:  Curr Rev Pain       Date:  2000

2.  Health status and management of chronic non-specific abdominal complaints in general practice.

Authors:  H A Janssen; J A Borghouts; J W Muris; J F Metsemakers; B W Koes; J A Knottnerus
Journal:  Br J Gen Pract       Date:  2000-05       Impact factor: 5.386

Review 3.  Labelling chronic illness in primary care: a good or a bad thing?

Authors:  John Bedson; Rob McCarney; Peter Croft
Journal:  Br J Gen Pract       Date:  2004-12       Impact factor: 5.386

4.  Relationship between overactive bladder and irritable bowel syndrome: a large-scale internet survey in Japan using the overactive bladder symptom score and Rome III criteria.

Authors:  Seiji Matsumoto; Kazumi Hashizume; Naoki Wada; Jyunichi Hori; Gaku Tamaki; Masafumi Kita; Tatsuya Iwata; Hidehiro Kakizaki
Journal:  BJU Int       Date:  2012-10-26       Impact factor: 5.588

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.